Balancing efficacy and safety in anticoagulation can be a challenge, especially for high-risk patients such as those with severe renal impairment1. Sometimes, real world evidence can also conflict with results from randomised controlled trials. Join Dr Chris Hammett, an interventional cardiologist at the Royal Brisbane and Women’s Hospital and Professor Jan Beyer-Westendorf, Head of the ...
Sponsored webinar: Myths and Misperceptions of anticoagulation: is bleeding the issue?
30 Jun 2020
Sponsored by Bayer Australia Limited